Amgen: Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An, Financial Statements And Exhibits
December 22, 2022
U.S. Securities and Exchange Commission
|Show full article|
This functionality is available for registred users only
Company — Amgen
Full nameAmgen, Inc.
IndustryPharmaceutical Preparation and Biotechnology